These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5959530)

  • 1. Effect of ethinyl estradiol (estinyl) on plasma renin activity.
    Crane MG; Heitsch J; Harris JJ; Johns VJ
    J Clin Endocrinol Metab; 1966 Dec; 26(12):403-6. PubMed ID: 5959530
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
    Kaulhausen H; Oehm W; Fritzsche G; Breuer H
    Z Klin Chem Klin Biochem; 1974 Sep; 12(9):408-14. PubMed ID: 4372825
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma renin activity and aldosterone excretion rate in normal subjects. II. Effect of oral contraceptive agents.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):558-62. PubMed ID: 5779248
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies on two combination oral contraceptives, one containing synthetic estrogen, the other "natural" estrogens.
    Saunders DM; Shuter B; Shearman RP
    Contraception; 1978 Nov; 18(5):527-34. PubMed ID: 729378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion.
    Newton MA; Sealey JE; Ledingham JG; Laragh JH
    Am J Obstet Gynecol; 1968 Aug; 101(8):1037-45. PubMed ID: 4298723
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of oral contraceptives on the renin-angiotensin system and on blood pressure of normal young women.
    Beckerhoff R; Luetscher JA; Beckerhoff I; Nokes GW
    Johns Hopkins Med J; 1973 Feb; 132(2):80-7. PubMed ID: 4346163
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma-aldosterone during oral-contraceptive therapy.
    Beckerhoff R; Vetter W; Armbruster H; Luetscher JA; Siegenthaler W
    Lancet; 1973 Jun; 1(7814):1218-9. PubMed ID: 4122566
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin activity and aldosterone excretion rate in normal subjects. I. Effect of ethinyl estradiol and medroxyprogesterone acetate.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1969 Apr; 29(4):550-7. PubMed ID: 5779247
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and responsiveness of plasma renin activity and blood pressure in normotensive women.
    Leenen FH; Boer P; Dorhaut Mees EJ
    Clin Exp Hypertens (1978); 1980 Feb; 2(2):197-211. PubMed ID: 6998682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of varying amounts of ethinyl oestradiol in the combined oral contraceptive on plasma sex hormone binding globulin capacity in normal women.
    Pogmore JR; Jequier AM
    Br J Obstet Gynaecol; 1979 Jul; 86(7):563-7. PubMed ID: 573132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system: oral contraception and exercise in healthy female subjects.
    Huisveld IA; Derkx FM; Bouma BN; Erich WB; Schalekamp MA
    J Appl Physiol (1985); 1985 Dec; 59(6):1690-7. PubMed ID: 3908438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethinyl estradiol on renin activity and on the concentrations of renin substrate and aldosterone in plasma of ovariectomized women.
    Kaulhausen H; Venn HJ; Mühlbauer W; Beck KJ; Breuer H
    Arch Gynecol; 1980 Jan; 229(1):29-36. PubMed ID: 6987956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
    Mandal B; Maity CR
    Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized prospective studies on metabolic effects of oral contraceptives.
    Briggs MH; Briggs M
    Acta Obstet Gynecol Scand Suppl; 1982; 105():25-32. PubMed ID: 6805241
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the study of synthetic progestinics. Analysis of a 17-hydroxyprogesterone derivative combined with ethinyl-estradiol].
    Peano M; Agnese M; Yammaki Y; Araujo Peano N; Groisman M; Canedo A; Correa A; Villano G; Cardoso A
    Minerva Ginecol; 1969 Dec; 21(24):1667-94. PubMed ID: 5374678
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral contraceptives and plasma amino-acids.
    Craft IL; Wise I
    Nature; 1969 May; 222(5192):487-8. PubMed ID: 5768631
    [No Abstract]   [Full Text] [Related]  

  • 19. D-norgestrel combined with ethinyl oestradiol as an oral contraceptive.
    McBride WG
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):177-85. PubMed ID: 4985938
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.